Clinical Trials

  • Johnson & Johnson's Impella CP heart pump is shown in an illustration of the heart.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J’s Impella heart pump shows no patient benefit in 2 trials

    Study investigators cautioned against routine use of the device in complex percutaneous coronary interventions and to treat heart attack patients who don’t have cardiogenic shock.

    By • April 1, 2026
  • Medtronic's Symplicity Spyral device is shown against a white background.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic to study renal denervation combined with PCI

    Medtronic detailed plans to further study the blood pressure treatment while releasing additional data from the SPYRAL HTN trials that showed the procedure reduced hypertensive emergencies.

    By • March 31, 2026
  • Intuitive Surgical's da Vinci 5 robotic system. Explore the Trendline➔
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • A rendering of a rounded device with a wire structure surrounded by mesh.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific posts positive stroke prevention data for Watchman

    The company said it will seek an expanded indication for the left atrial appendage closure device after it met all safety and efficacy goals in the closely watched CHAMPION-AF study.

    By • March 30, 2026
  • A rectangular, metallic device on a catheter sites next to three nickels.
    Image attribution tooltip
    Permission granted by Glucotrack
    Image attribution tooltip

    Glucotrack plans US trial of implantable glucose monitor this year

    Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the second half of 2026.

    By • March 27, 2026
  • Thermo Fisher Scientific
    Image attribution tooltip
    Courtesy of Thermo Fisher Scientific
    Image attribution tooltip

    Thermo Fisher completes $8.9B buyout of Clario

    Thermo Fisher plans to create a fast-growing business by integrating Clario’s data capture and management system with its existing capabilities.

    By • March 25, 2026
  • Professional photo of Ashley McEvoy
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip

    Insulet posts clinical data on fully closed-loop insulin delivery system

    The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

    By • March 12, 2026
  • Close up of a knee implant, showing the stem, which includes a gray extension.
    Image attribution tooltip
    Permission granted by Zimmer Biomet
    Image attribution tooltip

    Zimmer Biomet shares smart knee data at AAOS

    The orthopedic firm published data showing patients with its Persona IQ implant had lower revision and physical therapy rates than those who received traditional knee implants.

    By • March 6, 2026
  • Medical professional explaining brain scan results
    Image attribution tooltip
    SDI Productions via Getty Images
    Image attribution tooltip
    Sponsored by Infineon

    Transforming epilepsy care: How innovative implantable neurotechnology offers new hope

    Minimally invasive brain stimulation may be the new frontline treatment for drug-resistant patients.

    Feb. 23, 2026
  • Test tube blood
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Grail’s multi-cancer early detection test misses study goal

    Shares in the company lost about half their value in Friday trading after the clinical trial failed to demonstrate a statistically significant reduction in Stage III and IV cancers.

    By • Feb. 20, 2026
  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    4 takeaways from the 2026 AF Symposium

    Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation treatments, including pulsed field ablation catheters.

    By • Feb. 10, 2026
  • A picture of a medical catheter against a white background.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott details Volt, TactiFlex data; Pulse Biosciences’ results shine

    Abbott and Pulse released their findings at the AF Symposium that wrapped this weekend in Boston.

    By • Feb. 9, 2026
  • FDA sign
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Pulse Biosciences wins FDA approval to begin PFA catheter study

    Shorter, nanosecond pulses for treating atrial fibrillation differentiate the company’s approach from existing pulsed field ablation systems on the market.

    By • Dec. 18, 2025
  • AtriCure’s EnCompass Clamp device is shown against a white background.
    Image attribution tooltip
    Retrieved from AtriCure on December 12, 2025
    Image attribution tooltip

    AtriCure treats first patients with dual PFA/RF system

    Combining pulsed field ablation and a radiofrequency technique in one platform is expected to reduce procedure times.

    By • Dec. 12, 2025
  • V-Wave's implantable device for heart failure is shown next to a dime.
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip

    FDA advisory panel votes unanimously against J&J heart shunt

    Panelists focused on study data that showed the implant did not improve outcomes in heart failure patients.

    By • Dec. 5, 2025
  • A picture of MMI's Symani robotic surgery system.
    Image attribution tooltip
    Courtesy of MMI
    Image attribution tooltip

    MMI tackles Alzheimer’s; SS Innovations advances telesurgery

    MMI won FDA approval to study robotic surgery for Alzheimer’s disease. Elsewhere, SS Innovations’ CEO performed remote bypass surgery with a new console, and Procept BioRobotics’ Q3 revenue rose 43%.

    By • Nov. 10, 2025
  • A nurse consulting a doctor
    Image attribution tooltip
    sturti via Getty Images
    Image attribution tooltip
    Sponsored by IQVIA MedTech

    Designing smarter trials for new devices: 3 best practices for developers

    Discover three strategies for MedTech companies to design streamlined, effective trials and how quality data powers smarter study design.

    Nov. 3, 2025
  • Two clinicians view data showing the condition of a patient's arteries on a large screen.
    Image attribution tooltip
    Courtesy of Philips
    Image attribution tooltip

    3 takeaways from TCT 2025

    Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.

    By • Oct. 31, 2025
  • Thermo Fisher Scientific
    Image attribution tooltip
    Courtesy of Thermo Fisher Scientific
    Image attribution tooltip

    Thermo Fisher to acquire clinical trial data firm Clario for $8.9B

    The purchase is expected to complement Thermo’s clinical research services as companies are conducting more trials.

    By • Oct. 29, 2025
  • A coil-shaped device is shown moving through a tube with branching structures around it.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic links renal denervation to 3-year blood pressure reduction

    Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment after three years.

    By • Oct. 28, 2025
  • Person wears Oura ring in a car
    Image attribution tooltip
    Courtesy of Oura
    Image attribution tooltip

    Ōura to pursue FDA clearance of blood pressure feature for smart ring

    The company has received approval to validate and define the feature in a study that is scheduled to start this year.

    By • Oct. 20, 2025
  • Three clinicians in surgical garb view the screen at the console of Medtronic's Hugo robotic surgery system.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic begins study of Hugo robot in gynecology

    With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on Intuitive Surgical in the U.S. robotic surgery market.

    By • Oct. 9, 2025
  • A rendering of a rounded device with a wire structure surrounded by mesh.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific unveils plans for new Watchman device

    The company hopes to launch its next-generation Watchman system in the second half of 2027 or early 2028.

    By • Updated Oct. 14, 2025
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J launches IVL device in Europe; Medtronic looks at pacing for more patients

    J&J’s Shockwave Javelin intravascular lithotripsy catheter treats people with peripheral artery disease. Elsewhere, Medtronic began a pivotal trial to evaluate its pacemakers in a new patient group.

    By • Sept. 18, 2025
  • Pulse Biosciences' pulsed field ablation tool is displayed against a white background.
    Image attribution tooltip
    Permission granted by Pulse Biosciences
    Image attribution tooltip

    Pulse wins IDE approval; Galvanize pulls in $100M

    Pulse Biosciences will study PFA in cardiac surgery. Meanwhile, Galvanize Therapeutics also named a new CEO, and PFA pioneer Steven Mickelsen has launched another company.

    By • Sept. 9, 2025
  • Header Image
    Image attribution tooltip

    istockphoto.com/janiecbros

    Image attribution tooltip
    Sponsored by Veeva

    Smith+Nephew improves evidence generation by aligning clinical and medical affairs

    Clinical teams focus on generating evidence for a product's safety and efficacy, while medical affairs teams act as a bridge to the healthcare community.

    Sept. 8, 2025